WEEKLY e-ALERT  [ BASIC EDITION ]
Pharma China (www.pharmachinaonline.com) is the most influential English media and source of business intelligence covering the Chinese pharmaceutical sector. Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China’s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most MNC pharma companies, leading CROs, investment banks, consulting firms active in China as well as relevant industry associations and government agencies.

Note: To view full text of free articles, you need to register as a basic member first and then log in. To view premium articles, you need to subscribe to Pharma China as a premium member. For more information or subscription, please contact info@pharmachinaonline.com. If you wish to unsubscribe from this e-Alert, please reply this e-mail with "Remove" in the subject line.
Editor´s Picks
CFDA's New Draft Policy Introduces the Chinese Version of Patent Linkage(6/15/2017 )  (Premium)
APAC Is the Fastest Growing Market for CRO Industry(6/15/2017 )  (Premium)
The Market
Snapshot of Drug Sales of Representative Hospitals in Shanghai 2016(6/12/2017 )  (Premium)
Snapshot of Anti-hypertensive Drug Sales in Hospitals of Major Chinese Cities(6/12/2017 )  (Premium)
Industry News
GSK, GIRD Enter Big Data Alliance for COPD Registry and Asthma Management(6/16/2017 )  (Premium)
Croma-Pharma, Sihuan Pharma in Joint Venture Agreement in China(6/13/2017 )  (free)
Snapshot: Sanofi's Chinese Urban Hospital Drug Sales Up 5.4% in 2016(6/13/2017 )  (Premium)
Wuxi Biologics Launches IPO in Hong Kong(6/12/2017 )  (free)
Japanese Pharma Positions for Growing Lifestyle Diseases in China and Rest of Asia(6/12/2017 )  (Premium)
Windtree, Lee's Enter Into License Agreement for KL4 Surfactant Technology Platform in Asia(6/12/2017 )  (Premium)
CSL to Acquire Majority Stake in Plasma Product Producer Ruide Bio from Humanwell(6/12/2017 )  (Premium)
Snapshot of Novartis's Flat Chinese Urban Hospital Drug Sales in 2016(6/12/2017 )  (Premium)
Regulatory News
CFDA Entrusts CPIA to Solicit Comments on Draft Provisions for Registration of Drug Products(6/16/2017 )  (Premium)
China Cracks CNY 400M Pharmaceutical Invoice Fraud Case(6/16/2017 )  (Premium)
General Health
Anhui Slashes BMI Payment Prices of Drug Products(6/14/2017 )  (Premium)
Number of Private Hospitals Rising But Still Insignificant in China Healthcare(6/14/2017 )  (Premium)
NHFPC, SATCM Issue Joint Document to Crackdown on Healthcare Corruption(6/13/2017 )  (Premium)
Product/R&D News
BeiGene Presents Phase 1 Data on BTK Inhibitor BGB-3111 Combined with Obinutuzumab(6/16/2017 )  (Premium)
Six Agencies Issue Joint Special 13th FYP for Healthcare Industry Innovation(6/16/2017 )  (Premium)
China Investigates Claims of Academic Fraud Relating to Cancer Research(6/15/2017 )  (Premium)
Chi-Med Files Chinese NDA for Anticancer Fruquintinib(6/12/2017 )  (Premium)
People in the News
Recent Executive Moves(6/15/2017 )  (Premium)
Recent CFDA Senior Official Moves(6/12/2017 )  (Premium)
© Wicon International GroupˇˇSupport by: www.heightow.com Home | Site map | Contact Us | Links